[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fwMEhZ6tlWHcU5K47HBacczguzSFWoTY-vWZXS5GcnZk":8,"$fs0vx2ZsYpKDATDUCpl5JGF-cQdU75gbnV-o4HktsNq4":55,"$fqcRAIHgkQlN7q8bnifgxavyhBI0vsdp-hx9CBxdrb5A":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67001,867271,[],"https://ystcdn.venuertc.com/medical/ystApp/1KNmXQDnP2XagGmzBK1qyfRfTWA6Qk1r.png","李浩齐","缙云县新建镇中心卫生院","全科医疗","住院医师",516,0,"FOLFIRI联合贝伐珠单抗等药物的用药攻略：直肠恶性肿瘤用药一定要注意的实用细节","","https://ystcdn.venuertc.com/venue/AI/d9d4428b-b10d-43d3-80bd-da9a98fa8100.jpg","\u003Cdiv class=\"rectal-drug-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"rectal-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">FOLFIRI联合贝伐珠单抗等药物的用药攻略：直肠恶性肿瘤用药一定要注意的实用细节\u003C/h2>\n  \u003Cdiv class=\"rectal-lead\">\n    说起FOLFIRI化疗方案和贝伐珠单抗，很多人都听说过它们是治疗某些恶性肿瘤的重要药物组合。其实，从化疗到止吐、保肝再到升白，每一类药物都有严格的用法和安全要求。这篇用药全书就为您梳理\u003Cstrong>7个关键用药细节\u003C/strong>，帮您守好安全红线，同时提升效果，让全家人的用药都安心！🩺💊\n  \u003C/div>\n\n  \u003C!-- 01 剂型和成分：化疗组合用药从哪些药品组成？ -->\n  \u003Csection class=\"rectal-section\">\n    \u003Cdiv class=\"rectal-section-title\">01 🚩 药品组成与剂型简介\u003C/div>\n    \u003Cdiv class=\"rectal-section-bg\">\u003C/div>\n    \u003Cdiv class=\"rectal-content\">\n      FOLFIRI方案联合贝伐珠单抗，常用如下药品组成：\u003Cbr>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>伊立替康（Irinotecan）：\u003C/strong>注射剂，常用规格40mg/2ml或100mg/5ml。\u003C/li>\n        \u003Cli>\u003Cstrong>亚叶酸钙（Leucovorin）：\u003C/strong>注射剂，规格常见为50mg、100mg等。\u003C/li>\n        \u003Cli>\u003Cstrong>氟尿嘧啶（Fluorouracil, 5-FU）：\u003C/strong>注射剂，规格多为250mg、500mg/支。\u003C/li>\n        \u003Cli>\u003Cstrong>贝伐珠单抗（Bevacizumab）：\u003C/strong>注射剂，规格常见为100mg/4ml或400mg/16ml。\u003C/li>\n        \u003Cli>\u003Cstrong>托烷司琼、昂丹司琼：\u003C/strong>均为注射液或口服片剂，止吐用药。\u003C/li>\n        \u003Cli>\u003Cstrong>谷胱甘肽、甘草酸二铵：\u003C/strong>注射剂型多见，用于保肝。\u003C/li>\n        \u003Cli>\u003Cstrong>利可君：\u003C/strong>片剂或注射剂，用于升白细胞。\u003C/li>\n      \u003C/ul>\n      这些药物基本都为注射剂型，部分可口服（如利可君片）。化疗药物需在医院静脉输注，辅助用药按照需要选择剂型。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 用法用量：关键的使用方法说明 -->\n  \u003Csection class=\"rectal-section\">\n    \u003Cdiv class=\"rectal-section-title\">02 ⏰ 用法用量：怎么用，什么时候用？\u003C/div>\n    \u003Cdiv class=\"rectal-section-bg\">\u003C/div>\n    \u003Cdiv class=\"rectal-content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>FOLFIRI化疗（伊立替康、亚叶酸钙、氟尿嘧啶组合）\u003C/strong>: 按照体表面积和疗程，由医护人员制定剂量，严格静脉滴注。不同药物顺序和速度有明确要求，务必遵医嘱。\u003C/li>\n        \u003Cli>\u003Cstrong>贝伐珠单抗：\u003C/strong>通常每2周一次静脉滴注，输液速率从慢到快，首次需监测至少90分钟。\u003C/li>\n        \u003Cli>\u003Cstrong>辅助药物：\u003C/strong>\n          \u003Cul>\n            \u003Cli>托烷司琼、昂丹司琼等止吐药：在化疗前30-60分钟静脉注射或口服，必要时按需追加。\u003C/li>\n            \u003Cli>谷胱甘肽、甘草酸二铵：跟化疗周期同步静脉输注。\u003C/li>\n            \u003Cli>利可君：按需口服或静注，通常从化疗后第2-3天开始，疗程5-10天。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"rectal-tip\">正确做法：\u003C/span>所有注射药物严禁自行注射，务必由专业医疗人员完成。辅助用药须按照医生制定的方案定时、足量使用，不可随意更换顺序或剂型。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 作用机制：各药如何发挥作用？ -->\n  \u003Csection class=\"rectal-section\">\n    \u003Cdiv class=\"rectal-section-title\">03 ⚙️ 药理机制简介\u003C/div>\n    \u003Cdiv class=\"rectal-section-bg\">\u003C/div>\n    \u003Cdiv class=\"rectal-content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>伊立替康：\u003C/strong>抑制DNA拓扑异构酶I，阻断细胞分裂，主要影响快速分裂的细胞。\u003C/li>\n        \u003Cli>\u003Cstrong>氟尿嘧啶：\u003C/strong>为抗代谢药，通过干扰DNA合成发挥细胞毒性。\u003C/li>\n        \u003Cli>\u003Cstrong>亚叶酸钙：\u003C/strong>增强氟尿嘧啶细胞毒性，同时减轻骨髓抑制。\u003C/li>\n        \u003Cli>\u003Cstrong>贝伐珠单抗：\u003C/strong>人源化单克隆抗体，靶向血管内皮生长因子（VEGF），可抑制新血管生成。\u003C/li>\n        \u003Cli>\u003Cstrong>止吐药（托烷司琼、昂丹司琼）：\u003C/strong>选择性5-HT3受体拮抗剂，防止化疗相关的呕吐。\u003C/li>\n        \u003Cli>\u003Cstrong>谷胱甘肽、甘草酸二铵：\u003C/strong>具有抗氧化及保肝作用，用于防护肝脏细胞。\u003C/li>\n        \u003Cli>\u003Cstrong>利可君：\u003C/strong>促进骨髓造血，提升白细胞生成。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"rectal-question\">其实，正是这些机制共同助力，才确保了治疗方案的协同效果。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 副作用及处理：最常见的不适和应对措施 -->\n  \u003Csection class=\"rectal-section\">\n    \u003Cdiv class=\"rectal-section-title\">04 🤒 常见不良反应及处理方法\u003C/div>\n    \u003Cdiv class=\"rectal-section-bg\">\u003C/div>\n    \u003Cdiv class=\"rectal-content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>FOLFIRI相关的主要不适：\u003C/strong>\n          \u003Cul>\n            \u003Cli>白细胞减少（粒细胞缺乏），感染风险增高。\u003C/li>\n            \u003Cli>脱发、恶心、呕吐、腹泻等消化系统症状。\u003C/li>\n            \u003Cli>疲乏、口腔炎。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cstrong>贝伐珠单抗相关：\u003C/strong>常见高血压、出血、蛋白尿、过敏反应。\u003C/li>\n        \u003Cli>\u003Cstrong>辅助用药反应：\u003C/strong>\n          \u003Cul>\n            \u003Cli>止吐药可导致头痛、便秘。\u003C/li>\n            \u003Cli>谷胱甘肽、甘草酸二铵偶见皮疹、注射部位红肿。\u003C/li>\n            \u003Cli>利可君偶见过敏、发热。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"rectal-tip\">正确做法：\u003C/div>\n      \u003Col>\n        \u003Cli>化疗期间如出现严重发热、咽喉痛、长期腹泻或持续呕吐，需立刻就医。\u003C/li>\n        \u003Cli>如有出血倾向或者蛋白尿等异常，请主动告知医生。\u003C/li>\n        \u003Cli>辅助用药如出现皮疹、头晕、胸闷等，立即停药，并及时请医师处理。\u003C/li>\n      \u003C/ol>\n      \u003Cspan class=\"rectal-emoji\">💡临床数据：\u003C/span>文献数据显示，FOLFIRI方案白细胞减少率约为38-50%，贝伐珠单抗蛋白尿出现率约20%（Saltz et al., 2007; Hurwitz et al., 2004）。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 药物相互作用：哪些药不能一起用？ -->\n  \u003Csection class=\"rectal-section\">\n    \u003Cdiv class=\"rectal-section-title\">05 🔄 药物相互作用与用药搭配\u003C/div>\n    \u003Cdiv class=\"rectal-section-bg\">\u003C/div>\n    \u003Cdiv class=\"rectal-content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>贝伐珠单抗：\u003C/strong>严禁与含硫脲类抗甲状腺药物合用，以免加重白细胞减少。\u003C/li>\n        \u003Cli>\u003Cstrong>伊立替康：\u003C/strong>避免与酮康唑、利福平等强代谢酶诱导剂/抑制剂同时使用，以免影响疗效或增加毒性。\u003C/li>\n        \u003Cli>\u003Cstrong>氟尿嘧啶与抗病毒药物：\u003C/strong>与噻唑类等药合用时需加强监测骨髓抑制。\u003C/li>\n        \u003Cli>\u003Cstrong>多药并用常规：\u003C/strong>各药均应由专业医师严格搭配。自购或添加任何非处方药前，务必征询医生。\u003C/li>\n      \u003C/ul>\n      特别提醒：用药期间要主动告知医生所有正在服用的药品和健康品，包括中草药及保健品。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 适应症与禁忌症：哪些情况下不能用？ -->\n  \u003Csection class=\"rectal-section\">\n    \u003Cdiv class=\"rectal-section-title\">06 🚫 禁忌与特殊注意人群\u003C/div>\n    \u003Cdiv class=\"rectal-section-bg\">\u003C/div>\n    \u003Cdiv class=\"rectal-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>FOLFIRI方案：\u003C/strong>\n          \u003Cul>\n            \u003Cli>禁用于对氟尿嘧啶、伊立替康等任一成分过敏的人。\u003C/li>\n            \u003Cli>重度骨髓抑制、活动性严重感染及严重肝肾功能衰竭者禁用。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>贝伐珠单抗：\u003C/strong>\n          \u003Cul>\n            \u003Cli>严重出血性疾病、活动性溃疡、近期手术（创口未愈）患者禁用。\u003C/li>\n            \u003Cli>孕妇及哺乳期妇女禁用。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\u003Cstrong>辅助药物：\u003C/strong>\n          \u003Cul>\n            \u003Cli>止吐药忌与多种心律失常药合用。\u003C/li>\n            \u003Cli>谷胱甘肽、甘草酸二铵对相关成分过敏者禁用。\u003C/li>\n            \u003Cli>利可君禁用于急性白血病等特殊血液病。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"rectal-tip\">正确做法：\u003C/div>\n      \u003Cspan>首次使用前一定要由医师仔细评估身体状态，若有多种基础疾病，更要反复确认用药安全性。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 老年人及特殊群体用药调整 -->\n  \u003Csection class=\"rectal-section\">\n    \u003Cdiv class=\"rectal-section-title\">07 👵 👴 特殊人群与用量调整\u003C/div>\n    \u003Cdiv class=\"rectal-section-bg\">\u003C/div>\n    \u003Cdiv class=\"rectal-content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>老年人：\u003C/strong>肝肾功能减弱时，FOLFIRI方案和贝伐珠单抗往往需降低起始剂量，密切监测不良反应。\u003C/li>\n        \u003Cli>\u003Cstrong>肝肾功能不全者：\u003C/strong>需根据具体指标调整剂量，有肝衰患者，伊立替康多需减量。\u003C/li>\n        \u003Cli>\u003Cstrong>儿童：\u003C/strong>上述方案未足够研究，不推荐儿童人群随意使用。\u003C/li>\n        \u003Cli>\u003Cstrong>孕妇及哺乳期：\u003C/strong>严禁使用化疗及贝伐珠单抗。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"rectal-tip\">重点：\u003C/span>出现肝区不适、尿量减少、异常出血等需立刻停止相关药物。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 08 储存要求与操作管理 -->\n  \u003Csection class=\"rectal-section\">\n    \u003Cdiv class=\"rectal-section-title\">08 🏷️ 药品储存、有效期与过期处理\u003C/div>\n    \u003Cdiv class=\"rectal-section-bg\">\u003C/div>\n    \u003Cdiv class=\"rectal-content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>注射剂：\u003C/strong>必须存放于2-8°C冰箱冷藏，取出后尽快使用，避免受热或冷冻。\u003C/li>\n        \u003Cli>\u003Cstrong>片剂：\u003C/strong>需避光、密封保存于25°C以下干燥环境。\u003C/li>\n        \u003Cli>\u003Cstrong>开封后：\u003C/strong>注射剂一经开启须当天使用，用剩应弃掉。\u003C/li>\n        \u003Cli>\u003Cstrong>过期药物：\u003C/strong>不得自行使用，切忌随意丢弃，以防环境污染，可送至药房专用回收处。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 09 案例归纳与实用提醒 -->\n  \u003Csection class=\"rectal-section\">\n    \u003Cdiv class=\"rectal-section-title\">09 📋 临床用药案例经验\u003C/div>\n    \u003Cdiv class=\"rectal-section-bg\">\u003C/div>\n    \u003Cdiv class=\"rectal-content\">\n      \u003Cul>\n        \u003Cli>一位70岁男性在FOLFIRI+贝伐珠单抗治疗期间，因及时监测白细胞变化，辅助用上了利可君，较好地预防了感染。\u003C/li>\n        \u003Cli>有患者在使用贝伐珠单抗同时服用多种降压药，不经过医生指导，导致严重低血压、晕厥。强调搭配药物需慎重。\u003C/li>\n        \u003Cli>在化疗期间，因牢记每种药物的储存要求，未出现药效减弱或变质的情况。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"rectal-tip\">经验总结：\u003C/span>每次调整药物组合或剂量，必须交由专科医生评估后进行。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 10 总结：用药优势与安全关注点 -->\n  \u003Csection class=\"rectal-section\">\n    \u003Cdiv class=\"rectal-section-title\">10 📝 总结与关键提示\u003C/div>\n    \u003Cdiv class=\"rectal-section-bg\">\u003C/div>\n    \u003Cdiv class=\"rectal-content\">\n      FOLFIRI方案联合贝伐珠单抗治疗需严守用药时间、不随意更换剂型和用量，储存环境和药物搭配必须专业管控，不能自行处理突发不适。\u003Cbr>\n      \u003Cbr>\n      这类化疗药物虽然效果确切，但伴随风险不可小觑。\u003Cspan class=\"rectal-highlight\">务必重视：①每一种药物的专属性，②剂量和使用顺序，③所有用药调整都要知情确认。\u003C/span> \u003Cbr>\u003Cbr>\n      学会这些细节，让安全用药成为长期健康的第一步。如遇到用药疑惑，请及时和专业人员沟通，让治疗效果更稳更安心。🌱\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 参考文献 -->\n  \u003Csection class=\"rectal-section\">\n    \u003Cdiv class=\"rectal-section-title\">📑 文献与资料来源\u003C/div>\n    \u003Cdiv class=\"rectal-section-bg\">\u003C/div>\n    \u003Cdiv class=\"rectal-content\">\n      \u003Col>\n        \u003Cli>Saltz, L. B., Clarke, S., Díaz-Rubio, E., Scheithauer, W., Figer, A., Wong, R., ... & Lichinitser, M. (2007). Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. \u003Ci>Journal of Clinical Oncology\u003C/i>, 25(13), 1626–1634. https://doi.org/10.1200/JCO.2006.09.6305\u003C/li>\n        \u003Cli>Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., ... & Kabbinavar, F. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 350(23), 2335-2342. https://doi.org/10.1056/NEJMoa032691\u003C/li>\n        \u003Cli>Benson, A. B., Venook, A. P., Al-Hawary, M. M., et al. (2021). NCCN Guidelines Insights: Colon Cancer, Version 2.2021. \u003Ci>Journal of the National Comprehensive Cancer Network\u003C/i>, 19(3), 329-339.\u003C/li>\n        \u003Cli>Cunningham, D., Atkin, W., Lenz, H. J., et al. (2010). Colorectal cancer. \u003Ci>Lancet\u003C/i>, 375(9719), 1030-1047.\u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.rectal-drug-guide-container {\n  font-family: 'Helvetica Neue', Arial, 'PingFang SC', 'Microsoft YaHei', sans-serif;\n  background: #f9fbfd;\n  color: #222;\n  max-width: 820px;\n  margin: 32px auto 32px auto;\n  padding: 36px 28px 32px 28px;\n  border-radius: 14px;\n  box-shadow: 0 4px 24px rgba(22, 51, 150, 0.06);\n  line-height: 1.8;\n}\n.rectal-title {\n  font-size: 2.1em;\n  color: #3b4966;\n  margin-bottom: 20px;\n  font-weight: 700;\n  text-align: center;\n  letter-spacing: 1.2px;\n}\n.rectal-lead {\n  font-size: 1.18em;\n  background: linear-gradient(90deg, #fffbe6 0%, #f7f5fc 100%);\n  border-radius: 8px;\n  color: #543990;\n  padding: 16px 22px;\n  margin-bottom: 24px;\n  box-sizing: border-box;\n  font-weight: 500;\n}\n.rectal-section {\n  margin: 38px 0 0 0;\n  border-radius: 10px;\n  overflow: hidden;\n  box-shadow: 0 0px 12px rgba(90,118,191,0.05);\n  background: #fff;\n}\n.rectal-section-title {\n  font-size: 1.22em;\n  font-weight: 600;\n  padding: 14px 0 14px 18px;\n  color: #2d4668;\n  background: linear-gradient(90deg, #eaf0fa 10%, #e5f0fb 65%, #f6f7fa 100%);\n  border-left: 5px solid #7cb1f3;\n  position: relative;\n  z-index: 1;\n  display: flex;\n  align-items: center;\n}\n.rectal-section-bg {\n  min-height: 14px;\n  width: 100%;\n  background: url('data:image/svg+xml;utf8,\u003Csvg width=\"400\" height=\"14\" viewBox=\"0 0 400 14\" fill=\"none\" xmlns=\"http://www.w3.org/2000/svg\">\u003Crect width=\"400\" height=\"14\" fill=\"%23eaf0fa\"/>\u003Cellipse cx=\"200\" cy=\"7\" rx=\"185\" ry=\"6\" fill=\"%23dde6f8\" fill-opacity=\"0.4\"/>\u003C/svg>') no-repeat center top;\n  background-size: cover;\n}\n.rectal-content {\n  padding: 20px 20px 14px 30px;\n  font-size: 1.07em;\n  color: #22293a;\n}\n.rectal-content ul {\n  padding-left: 18px;\n  margin: 0 0 10px 0;\n}\n.rectal-content ol {\n  padding-left: 26px;\n  margin: 0 0 10px 0;\n}\n.rectal-tip {\n  display: inline-block;\n  color: #2d65b0;\n  font-weight: 600;\n  padding-left: 2px;\n  font-size: 1em;\n}\n.rectal-emoji {\n  color: #e38e55;\n  font-size: 1.09em;\n  padding-left: 3px;\n}\n.rectal-section-title strong,\n.rectal-content strong {\n  color: #1f76cc;\n}\n.rectal-question {\n  display: block;\n  color: #8a47a6;\n  margin-top: 10px;\n  margin-bottom: 5px;\n  font-size: 0.95em;\n  font-style: italic;\n}\n.rectal-highlight {\n  background: linear-gradient(90deg, #fbeee6 40%, #f3f7fa 100%);\n  border-radius: 4px;\n  padding: 1px 6px;\n  color: #a15324;\n  font-weight: 600;\n}\n@media (max-width: 560px) {\n  .rectal-drug-guide-container {\n    padding: 16px 4vw;\n  }\n  .rectal-content {\n    padding: 14px 3vw 6px 4vw;\n  }\n  .rectal-title {\n    font-size: 1.13em;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"rectal-drug-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"rectal-title\" style=\"colo",518,"2025-09-23 13:49:40","FOLFIRI, 贝伐珠单抗, 直肠恶性肿瘤, 化疗方案, 药物副作用, 用药安全, 医疗建议","深入分析FOLFIRI及贝伐珠单抗的安全用药细节，助您有效应对恶性肿瘤化疗中的风险与副作用。符合目标人群需求，让每一步用药都更安全！","2025-10-03 19:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]